Interaction of Diet and the Masou Salmon Δ5-desaturase Transgene on Δ6-desaturase and Stearoyl-CoA Desaturase Gene Expression and N-3 Fatty Acid Level in Common Carp (Cyprinus Carpio)
Overview
Authors
Affiliations
The masou salmon Δ5-desaturase-like gene (D5D) driven by the common carp β-actin promoter was transferred into common carp (Cyprinus carpio) that were fed two diets. For P1 transgenic fish fed a commercial diet, Δ6-desaturase-like gene (D6D) and stearoyl-CoA desaturase (SCD) mRNA levels in muscle were up-regulated (P < 0.05) 12.7- and 17.9-fold, respectively, and the D6D mRNA level in the gonad of transgenic fish was up-regulated 6.9-fold (P < 0.05) compared to that of non-transgenic fish. In contrast, D6D and SCD mRNA levels in transgenic fish were dramatically down-regulated (P < 0.05), 50.2- and 16.7-fold in brain, and 5.4- and 2.4-fold in liver, respectively, in comparison with those of non-transgenic fish. When fed a specially formulated diet, D6D and SCD mRNA levels in muscle of transgenic fish were up-regulated (P < 0.05) 41.5- and 8.9-fold, respectively, and in liver 6.0- and 3.3-fold, respectively, compared to those of non-transgenic fish. In contrast, D6D and SCD mRNA levels in the gonad of transgenic fish were down-regulated (P < 0.05) 5.5- and 12.4-fold, respectively, and D6D and SCD mRNA levels in the brain were down-regulated 14.9- and 1.4-fold (P < 0.05), respectively, compared to those of non-transgenic fish. The transgenic common carp fed the commercial diet had 1.07-fold EPA, 1.12-fold DPA, 1.07-fold DHA, and 1.07-fold higher observed total omega-3 fatty acid levels than non-transgenic common carp. Although these differences were not statistically different (P > 0.05), there were significantly (P < 0.10) higher omega-3 fatty acid levels when considering the differences for all of the individual omega-3 fatty acids. The genotype × diet interactions observed indicated that the potential of desaturase transgenesis cannot be realized without using a well-designed diet with the needed amount of substrates.
Coogan M, Xing D, Su B, Alston V, Johnson A, Khan M Transgenic Res. 2023; 32(4):251-264.
PMID: 37468714 DOI: 10.1007/s11248-023-00346-w.
Qin G, Qin Z, Lu C, Ye Z, Elaswad A, Jin Y Biology (Basel). 2023; 12(3).
PMID: 36979084 PMC: 10044888. DOI: 10.3390/biology12030392.
Qin G, Qin Z, Lu C, Ye Z, Elaswad A, Bangs M Biology (Basel). 2022; 11(5).
PMID: 35625377 PMC: 9138287. DOI: 10.3390/biology11050649.
Xing D, Su B, Li S, Bangs M, Creamer D, Coogan M Mar Biotechnol (NY). 2022; 24(3):513-523.
PMID: 35416602 DOI: 10.1007/s10126-022-10110-6.
Huang Y, Bugg W, Bangs M, Qin G, Drescher D, Backenstose N Transgenic Res. 2021; 30(2):185-200.
PMID: 33792795 DOI: 10.1007/s11248-021-00242-1.